Leishmaniasis
From Anvita Health Wiki
Contents |
More Specific Terms
- cutaneous leishmaniasis (oriental sore)
- mucocutaneous leishmaniasis (espundia)
- visceral leishmaniasis (kala-azar)
Introduction
- A disease of the reticuloendothelial system caused by protozoa of the genus Leishmania.
Epidemiology
Laboratory
- (also see visceral leishmaniasis)
- light microscopy for visualization of amastigotes in smears, imprints or biopsies
- growth of promastigotes in culture
- Novy-MacNeal-Nicolle's medium
- Schneider's Drosophila media supplemented with fetal calf serum
- cultures show promastigotes in 2-5 days, but should be held for 4 weeks
- 2-4 um in size
- delicate cytoplasm, a nucleus & a kinetoplast
- may appear smaller due to shrinkage with fixation
- Leishmania have a kinetoplast, but no cell wall
- distingush from Histoplasma capsulatum & Toxoplasma gondii
- immunohistochemistry with monoclonal antibodies is species-specific
- polymerase-chain reaction ( PCR) is species-specific
Management
-
- available from CDC (404 639-3670)
- 20 mg Sb[V]/kg IM/ IV for 20 days (cutaneous) & 28 days visceral leishmaniasis
- (also see cutaneous, mucocutaneous & visceral leishmaniasis)
More General Terms
Additional Terms
References
- Clinical Diagnosis & Management by Laboratory Methods, 19th edition, J.B. Henry (ed), W.B. Saunders Co., Philadelphia, PA. 1996, pg 1266-68
- DeGowin & DeGowin's Diagnostic Examination, 6th edition, RL DeGowin (ed), McGraw Hill, NY 1994, pg 902-3
- Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 1189-93
